University of Vermont Cancer Center Member Profile
Steven Ades, MD
Professor, Medicine-Hematology Oncology
Director, Clinical Trial Office
Full Member
Cancer Host and Environment (CHE)
Academic Interests
My research focuses on multiple dimensions of supportive care for patients with cancer including improving the identification of cancer patients who are at the highest risk of developing deep venous clots or pulmonary embolism and how to prevent these complications from occurring. Clinically, I subspecialize in gastrointestinal and genitourinary cancer and have led or participated in clinical research programs within those disease site trans-disciplinary teams since joining the UVM Cancer Center in 2007.
Postdoctoral Training
2002-2005..... Masters Degree in Epidemiology and Biostatistics, McGill University, Montreal, QC
2000-2002..... Research Fellow, Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, MA
1999-2002..... Hematology/Oncology Fellowship, Tufts University, Boston MA
1996-1999..... Queens University postgraduate education in Internal Medicine (Kingston, Ontario)
Education
1992-1996..... McGill University, Montreal, Canada; MD Medicine
1989-1992..... McGill University, Montreal Canada; BS Chemistry
Publications
To view more and/or the most recent publications by Steven Ades please visit their biblography here.
Higgins LM, Lester-Coll NH, Ades S, Barry MM, Borrazzo EC, Ganguly EK, Anker CJ.
'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving
trimodality and bimodality therapy for esophageal cancer. J Gastrointest Oncol. 2023 Apr 29;14(2):480-493. PMID: 37201058
Ades S, Holmes CE. Implementing guidelines to prevent cancer associated thrombosis: how can we do better? Res Pract Thromb Haemost. 2023 Jan 10;7(1). PMID: 36852109
Stapleton RD, Ford DW, Sterba KR, Nadig NR, Ades S, Back AL, Carson SS, Cheung KL, Ely J, Kross EK, Macauley RC, Maguire JM, Marcy TW, McEntee JJ, Menon PR, Overstreet A, Ritchie CS, Wendlandt B, Ardren SS, Balassone M, Burns S, Choudhury S, Diehl S, McCown E, Nielsen EL, Paul SR, Rice C, Taylor KK, Engelberg RA. Evolution of Investigating Informed Assent Discussions about CPR in Seriously Ill Patients. J Pain Symptom Manage. 2022 Jun; 63(6):e621-e632. PMID: 35595375
Ades S, Pulluri B, Holmes C, Lal I, Kumar S, Littenberg B. Risk factors for venous
thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysis. Cancer Medicine. 2022. 11(8): 1817-26
Anker CJ, Lester-Coll NH, Akselrod D, Cataldo PA, Ades S. The Potential for
Overtreatment with Total Neoadjuvant Therapy (TNT): Consider One Local Therapy
Instead. Clinical Colorectal Cancer. 2022
Anker CJ, Akselrod D, Ades S, Bianchi NA, Lester-Coll NH, Cataldo PA. Non-Operative
Management (NOM) of Rectal Cancer: Literature Review & Translating Evidence into
Practice. Current Colorectal Cancer Reports. 2021;17(1):23–41.
Ades S, Adrianzen Herrera D, Lahey T, Thomas AA, Jasra S, Barry M, Sprague J, Dittus, Plante TB, Kelly J, Kaufman PA, Khan F, Hammond CJ, Gernander K, Parsons P, Holmes C. Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect. JCO Oncology Practice. 2021. Accepted on July 2, 2021 and published at ascopubs.org/journal/op on August 2, 2021: DOI https://doi.org/10. 1200/OP.21.00116
Lester-Coll NH, Ades S, Yu JB, Atherly A, Wallace HJ, Sprague BL. Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer. JAMA Network Open, 2021;4(1):e2033787. doi:10.1001. PMID 2774904
My research focuses on multiple dimensions of supportive care for patients with cancer including improving the identification of cancer patients who are at the highest risk of developing deep venous clots or pulmonary embolism and how to prevent these complications from occurring. Clinically, I subspecialize in gastrointestinal and genitourinary cancer and have led or participated in clinical research programs within those disease site trans-disciplinary teams since joining the UVM Cancer Center in 2007.
Postdoctoral Training
2002-2005..... Masters Degree in Epidemiology and Biostatistics, McGill University, Montreal, QC
2000-2002..... Research Fellow, Center for Adaptation Genetics and Drug Resistance, Tufts University School of Medicine, Boston, MA
1999-2002..... Hematology/Oncology Fellowship, Tufts University, Boston MA
1996-1999..... Queens University postgraduate education in Internal Medicine (Kingston, Ontario)
Education
1992-1996..... McGill University, Montreal, Canada; MD Medicine
1989-1992..... McGill University, Montreal Canada; BS Chemistry
Publications
To view more and/or the most recent publications by Steven Ades please visit their biblography here.
Higgins LM, Lester-Coll NH, Ades S, Barry MM, Borrazzo EC, Ganguly EK, Anker CJ.
'CROSS'-ing into the 'Real World': a retrospective cohort study of patients receiving
trimodality and bimodality therapy for esophageal cancer. J Gastrointest Oncol. 2023 Apr 29;14(2):480-493. PMID: 37201058
Ades S, Holmes CE. Implementing guidelines to prevent cancer associated thrombosis: how can we do better? Res Pract Thromb Haemost. 2023 Jan 10;7(1). PMID: 36852109
Stapleton RD, Ford DW, Sterba KR, Nadig NR, Ades S, Back AL, Carson SS, Cheung KL, Ely J, Kross EK, Macauley RC, Maguire JM, Marcy TW, McEntee JJ, Menon PR, Overstreet A, Ritchie CS, Wendlandt B, Ardren SS, Balassone M, Burns S, Choudhury S, Diehl S, McCown E, Nielsen EL, Paul SR, Rice C, Taylor KK, Engelberg RA. Evolution of Investigating Informed Assent Discussions about CPR in Seriously Ill Patients. J Pain Symptom Manage. 2022 Jun; 63(6):e621-e632. PMID: 35595375
Ades S, Pulluri B, Holmes C, Lal I, Kumar S, Littenberg B. Risk factors for venous
thromboembolism in metastatic colorectal cancer with contemporary treatment: A SEER-Medicare analysis. Cancer Medicine. 2022. 11(8): 1817-26
Anker CJ, Lester-Coll NH, Akselrod D, Cataldo PA, Ades S. The Potential for
Overtreatment with Total Neoadjuvant Therapy (TNT): Consider One Local Therapy
Instead. Clinical Colorectal Cancer. 2022
Anker CJ, Akselrod D, Ades S, Bianchi NA, Lester-Coll NH, Cataldo PA. Non-Operative
Management (NOM) of Rectal Cancer: Literature Review & Translating Evidence into
Practice. Current Colorectal Cancer Reports. 2021;17(1):23–41.
Ades S, Adrianzen Herrera D, Lahey T, Thomas AA, Jasra S, Barry M, Sprague J, Dittus, Plante TB, Kelly J, Kaufman PA, Khan F, Hammond CJ, Gernander K, Parsons P, Holmes C. Cancer Care in the Wake of a Cyberattack: How to Prepare and What to Expect. JCO Oncology Practice. 2021. Accepted on July 2, 2021 and published at ascopubs.org/journal/op on August 2, 2021: DOI https://doi.org/10. 1200/OP.21.00116
Lester-Coll NH, Ades S, Yu JB, Atherly A, Wallace HJ, Sprague BL. Cost-effectiveness of Prostate Radiation Therapy for Men With Newly Diagnosed Low-Burden Metastatic Prostate Cancer. JAMA Network Open, 2021;4(1):e2033787. doi:10.1001. PMID 2774904